INS and heart failure: In clinical studies, the presence of other long-standing environmental risk factors (high fat diet, sedentary lifestyle, smoking) and resulting co-morbidities (obesity, insulin, resistance, atherosclerosis, hypertension) together with the need for concomitant drug therapy in human heart failure patients complicate efforts to directly determine the effects of pharmacologic agents that alter cardiac or systemic glucose homeostasis.